![Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 - The Lancet Infectious Diseases Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/4f775784-4453-4c08-98f1-01483f865da7/gr1_lrg.jpg)
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 - The Lancet Infectious Diseases
![Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/b9c057e0-e68d-4608-9700-73b19be518ae/gr1.jpg)
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine
![Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus | Virology Journal | Full Text Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus | Virology Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12985-020-01334-w/MediaObjects/12985_2020_1334_Fig1_HTML.png)
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus | Virology Journal | Full Text
![Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | SpringerLink Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00109-019-01844-3/MediaObjects/109_2019_1844_Fig1_HTML.png)
Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | SpringerLink
![Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy | Journal for ImmunoTherapy of Cancer Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/9/e003218/F1.large.jpg)
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy | Journal for ImmunoTherapy of Cancer
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial | PLOS Medicine
![Schematic illustrating the prime-boost concept. Note: High levels of... | Download Scientific Diagram Schematic illustrating the prime-boost concept. Note: High levels of... | Download Scientific Diagram](https://www.researchgate.net/publication/311510742/figure/fig1/AS:613914932936705@1523380134074/Schematic-illustrating-the-prime-boost-concept-Note-High-levels-of-antibodies-and.png)
Schematic illustrating the prime-boost concept. Note: High levels of... | Download Scientific Diagram
![COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V) COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)](https://www.pcronline.com/var/pcrov3/storage/images/media/pcr/news/2021/sputnik-vaccine/14187886-1-eng-GB/sputnik-vaccine_imagefull.jpg)
COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)
![Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus? Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?](https://www.frontiersin.org/files/MyHome%20Article%20Library/476663/476663_Thumb_400.jpg)
Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
![How the Interval between Prime and Boost Injection Affects the Immune Response in a Computational Model of the Immune System How the Interval between Prime and Boost Injection Affects the Immune Response in a Computational Model of the Immune System](https://static.hindawi.com/articles/cmmm/volume-2012/842329/figures/842329.fig.003.jpg)
How the Interval between Prime and Boost Injection Affects the Immune Response in a Computational Model of the Immune System
![Vaccines | Free Full-Text | Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium Vaccines | Free Full-Text | Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium](https://www.mdpi.com/vaccines/vaccines-11-00378/article_deploy/html/images/vaccines-11-00378-g001.png)
Vaccines | Free Full-Text | Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
![Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection - ScienceDirect Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0001706X15300607-fx1.jpg)
Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection - ScienceDirect
![Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.9b01523/asset/images/medium/ja-2019-01523w_0007.gif)
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
![Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222000385-ga1.jpg)
Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect
![Vaccines | Free Full-Text | Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium Vaccines | Free Full-Text | Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium](https://www.mdpi.com/vaccines/vaccines-11-00378/article_deploy/html/images/vaccines-11-00378-g001-550.jpg)
Vaccines | Free Full-Text | Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
![Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41541-020-0189-2/MediaObjects/41541_2020_189_Fig2_HTML.png)